Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

BioRestorative Therapies, Inc. (BRTX)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   S-1/A10-K10-K10-K10-K10-K10-K10-K
Revenues  0.10.10.10.10.00.60.40.0
            Revenues growth  -40.8%17.1%37.0%122.8%-94.2%51.2%24661.7%-89.2%
Operating expenses:          
Research and development  0.91.71.52.22.92.11.41.6
General and administrative  1.84.64.03.93.23.92.32.3
    Total operating expenses  6.28.67.88.57.87.55.110.1
    Loss from operations  -2.8-8.4-7.6-8.4-7.8-7.2-4.9-4.8
            Operating margin  -3574.1%-6486.2%-6889.8%-10338.6%-21414.0%-1140.1%-1183.3%-282873.2%
   
Other (income) expense:          
Other income, net  1.33.62.30.60.50.30.50.4
Total other (income) expense  -8.5-6.2-4.9-1.1-0.9-0.8-0.7-1.0
    Net loss  -11.3-14.6-12.5-9.4-8.6-7.9-5.6-5.8
   
Net Loss Per Share - Basic  ($28.56)($0.66)($1.64)($1.74)($2.10)($3.20)($4.38)($0.35)
Net Loss Per Share - Diluted  ($28.56)($0.66)($1.64)($1.74)($2.10)($3.20)($4.38)($0.35)
   
Weighted Average Number of Common Shares Outstanding - Basic  0.422.37.65.44.12.51.316.5
Weighted Average Number of Common Shares Outstanding - Diluted  0.4       

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy